<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Algorithm for immediate treatment of hypereosinophilia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Algorithm for immediate treatment of hypereosinophilia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Algorithm for immediate treatment of hypereosinophilia</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">HE: hypereosinophilia; AEC: absolute eosinophil count.<br/>* Peripheral blood HE is defined AEC &gt;1.5 × 10<sup>9</sup>/L or &gt;1500/microL.<br/>¶ Tissue HE is defined by:

<ul>
<li>On bone marrow section, a percentage of eosinophils that exceeds 20% of all nucleated cells, and/or</li>
<li>Tissue infiltration that is extensive in the opinion of a pathologist and/or</li>
<li>Marked deposition of eosinophil granule proteins in tissue (in the absence or presence of major tissue infiltration by eosinophils).</li>
</ul>

Δ Refer to the UpToDate topic on clinical manifestations, pathophysiology, and diagnosis of hypereosinophilic syndromes.<br/><span class="lozenge">◊</span> Potentially life-threatening complications of HE include:

<ul>
<li>Acute heart failure or evidence of likely developing eosinophil-mediated cardiac damage (based on either clinical findings or elevated troponins when clinical cardiac impairment is not yet clinically evident).</li>
<li>Thromboemboli, often of cardiac origin, which can present as diffuse watershed central nervous system (CNS) infarctions or focal CNS thromboemboli.</li>
<li>Pulmonary signs or symptoms, in concert with substantial eosinophil-associated disease on computed tomography (CT) imaging of the chest.</li>
</ul></div><div id="graphicVersion">Graphic 103933 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
